Effect of anti-tuberculosis treatment on the tuberculin interferon-γ response in tuberculin skin test (TST) positive health care workers and patients with tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 6, 2000, Pages 555-561

  Stuart, R L ^a,b   Olden, D ^a   Johnson, P D R ^a   Forbes, A ^b   Bradley, P M ^c   Rothel, J S ^c   Grayson, M L ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c CSL LIMITED   (Australia)

Author keywords

Diagnosis; Gamma interferon; Tuberculosis

Indexed keywords

GAMMA INTERFERON; ISONIAZID; PYRIDOXINE; TUBERCULIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; COMBINATION CHEMOTHERAPY; DRUG EFFECT; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MONITORING; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ALLIED HEALTH PERSONNEL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0034126673     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Edwards P Q, Edwards L B. The story of the tuberculin test. Am Rev Respir Dis 1960; 81: 1-45.
2. Comstock G W. False tuberculin test results. Chest 1975; 68: 465-469.
3. Huebner R E, Schein M F, Bass J B. The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975.
4. Horowitz H W, Luciano B B, Kadel J R, Wormser G P. Tuberculin skin test conversion in hospital employees vaccinated with bacille Calmette-Guerin: Recent Mycobacterium tuberculosis infection or booster effect? Am J Infect Control 1995; 23: 181-187.
5. Wood P, Corner L, Plackett P. Development of a simple, rapid in vitro cellular assay for bovine tuberculosis based on the production of gamma interferon. Res Vet Sci 1990; 49: 46-49.
6. Wood P, Corner L, Rothel J, et al. Field comparison of the interferon-gamma assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis. Aust Vet J 1991; 68: 286-290.
7. Mukherjee S, Lumb R, Robinson P, Stapledon R. Evaluation of gamma interferon (IFN-gamma) assay in human mycobacterial infection. Aust NZ J Med 1995; 25: 436.
8. Desem N, Jones S L. Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of mycobacterium tuberculosis infection. Clin Diagn Lab Immunol 1998; 5: 531-536.
9. Streeton J A, Desem N, Jones S L. Sensitivity and specificity of a gamma-interferon blood test for tuberculosis. Int J Tuberc Lung Dis 1998; 2: 443-450.
10. Converse P J, Jones S L, Astemborski J, Vlahov D, Graham N M H. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: Effect of human immunodeficiency virus infection. J Infect Dis 1997; 176: 144-150.
11. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990; 142: 725-735.
12. Havlir D, van der kuyp F, Duffy E, Marshall R, Hom D, Ellner J. Nineteen year follow-up of tuberculin reactors: assessment of skin test reactivity and in vitro lymphocytic response. Chest 1991; 99: 1172-1176.
13. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Clin Infect Dis 1995; 21: 9-27.
14. National Health and Medical Research Council. The Australian immunisation handbook. 6 ed. Canberra: Australian Government Publishing Service, 1997.
15. Stuart R L, Bennett N, Grayson M L. A paired comparison of TST results using 5 vs 10 TU of tuberculin. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999.
16. National Health and Medical Research Council. Tuberculosis in Australia and New Zealand into the 1990s. Canberra: Australian Government Publishing Service, 1990.
17. CSL Biosciences. QuantiFERON-TB A test of cell mediated immunity for the detection of tuberculosis and atypical infection in humans. Direction Circular. Melbourne, Australia: CSL Ltd, 1996.
18. World Health Organization. Global tuberculosis control. WHO report 1998. Geneva: WHO, 1998.
19. Rooney J J, Crocco J A, Kramer C, Lyons H A. Further observations on tuberculin reactions in active tuberculosis. Am J Med 1976; 60: 517-522.
20. Hirsch C S, Hussain R, Toosi Z, Dawood G, Shahid F, Ellner J J. Cross-modulation by transforming growth factor Beta in human tuberculosis: Suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA 1996; 93: 3193-3198.
21. Ellner J J. The immune response in human tuberculosis: implications for tuberculosis control. J Infect Dis 1997; 176: 1351-1359.
22. Comstock G W, Livesay V T, Woolpert S F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131-137.
23. Ferebee S H. Controlled chemoprophylaxis trials in tuberculosis - A general review. Adv Tuberc Res 1970; 17: 28-106.
24. Ellner J J. Regulation of the human immune response during tuberculosis. J Lab Clin Med 1997; 130: 469-475.
25. Philipp W, Nair S, Guglielmi G, Lagranderie M, Gicquel B, Cole S. Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacerium tuberculosis H37Rv and from M. bovis. Microbiology 1996; 142: 3135-3145.
26. Harboe M, Malin A, Dockerell H, et al. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun 1998; 66: 717-723.
27. Pollock J M, Anderson P. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis 1997; 175: 1251-1254.
28. Haslov K, Anderson A, Nagai S, Gottschau A, Sorensen T, Anderson P. Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63: 804-810.
29. Johnson P D, Stuart R L, Grayson M, et al. Tuberculin-purified protein derivative-, MPT-64- and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterial bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 1999; 6: 934-937.